The ESCEO-IOF Young Investigator Awards were presented to twenty-three young investigators from 16 countries in recognition of their contributions to the field of bone and mineral research, based on the quality of their abstracts submitted to the WCO-IOF-ESCEO 2026 in Prague.

The Awards were presented on April 18th, 2026, by Professor Nicholas Harvey (IOF President) and Professor Jean-Yves Reginster,  ESCEO President. 

IOF and ESCEO congratulate the young investigators on their achievements and wish them continued success in their research and future careers.

The awardees:

• Mohamed Abdelsalam (Egypt)
• Selma Ben Hamouda (Tunisia)
• Fanny Buckinx (Belgium)
• Natália Casonato (Brazil)
• Damla Gul Cetin (Türkiye)
• Pantalius NjiChe (Cameroon)
• Simone Donati  (Italia)
• Guillaume Gatineau (France)
• Taras Griadil (Ukraine)
• Jui-Yo Hsu (China)
• Laurence Lapauw (Belgium)
• Faidra Laskou  (United Kingdom)
• Alix Mackowiak (Belgium)
• Sarra Mhamdi (Tunisia)
• Narangerel Enkhtaivan (Mongolia)
• Şirin Zelal Şahin Tırnova (Türkiye)
• Rathapoom Suwanaratana (Thailand)
• Alexandra-Ioana Trandafir (Romania)
• Sophie Van Heden (Belgium)
• Anna Walstra (Netherlands)
• Leo Westbury (United Kingdom)
• Yafa Ben Slama (Tunisia)
• Marguerite O'Riordan (Ireland)

###

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Prague 2026)

Held jointly by IOF and ESCEO, the Congress takes place in Prague, Czech Republic, April 16-19, 2026. WCO-IOF-ESCEO is the world’s largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including skeletal rare disorders, sarcopenia and frailty. For complete information visit www.wco-iof-esceo.org  #OsteoCongress

About ESCEO

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policymakers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, from an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org

About IOF

The International Osteoporosis Foundation (IOF) is the world’s largest nongovernmental organization dedicated to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases. Its members — including committees of leading scientific researchers and 349 patient, medical, and research organizations across 152 countries — work together to make fracture prevention and healthy mobility a global healthcare priority.www.osteoporosis.foundation   @iofbonehealth